Clinical Trial Update: Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial is recruiting to evaluate safety and preliminary efficacy of TS-2021 for recurrent malignant glioma, including glioblastoma and other mal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Malignant Glioma

Drugs mentioned

• TS-2021

Snippet

Sponsor: Beijing Neurosurgical Institute | Conditions: Glioblastoma Multiforme, Glioma, Malignant | Phase 1 | Status: RECRUITING